Fusion Genes Altered in Adult Malignant Gliomas
Malignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and ma...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/full |
id |
doaj-f8fa32b7c921434984fbb3d8f65d0c34 |
---|---|
record_format |
Article |
spelling |
doaj-f8fa32b7c921434984fbb3d8f65d0c342021-10-04T05:29:03ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-10-011210.3389/fneur.2021.715206715206Fusion Genes Altered in Adult Malignant GliomasGan You0Gan You1Xing Fan2Huimin Hu3Tao Jiang4Tao Jiang5Clark C. Chen6Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Neurophysiology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurophysiology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, ChinaDepartment of Molecular Pathology, Beijing Neurosurgical Institute, Beijing, ChinaDepartment of Neurosurgery, University of Minnesota, Minneapolis, MN, United StatesMalignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and may serve as novel therapeutic targets to date. Understanding the gene fusions and how they regulate oncogenesis and malignant progression will contribute to explore new approaches for personalized treatment. By now, studies on gene fusions in gliomas remain limited. However, some current clinical trials targeting fusion genes have presented exciting preliminary findings. The aim of this review is to summarize all the reported fusion genes in high-grade gliomas so far, discuss the characterization of some of the most popular gene fusions occurring in malignant gliomas, as well as their function in tumorigenesis, and the underlying clinical implication as therapeutic targets.https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/fullfusion genehigh-grade gliomaglioblastomatargeted therapypersonalized cancer medicine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gan You Gan You Xing Fan Huimin Hu Tao Jiang Tao Jiang Clark C. Chen |
spellingShingle |
Gan You Gan You Xing Fan Huimin Hu Tao Jiang Tao Jiang Clark C. Chen Fusion Genes Altered in Adult Malignant Gliomas Frontiers in Neurology fusion gene high-grade glioma glioblastoma targeted therapy personalized cancer medicine |
author_facet |
Gan You Gan You Xing Fan Huimin Hu Tao Jiang Tao Jiang Clark C. Chen |
author_sort |
Gan You |
title |
Fusion Genes Altered in Adult Malignant Gliomas |
title_short |
Fusion Genes Altered in Adult Malignant Gliomas |
title_full |
Fusion Genes Altered in Adult Malignant Gliomas |
title_fullStr |
Fusion Genes Altered in Adult Malignant Gliomas |
title_full_unstemmed |
Fusion Genes Altered in Adult Malignant Gliomas |
title_sort |
fusion genes altered in adult malignant gliomas |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2021-10-01 |
description |
Malignant gliomas are highly heterogeneous brain tumors in molecular genetic background. Despite the many recent advances in the understanding of this disease, patients with adult high-grade gliomas retain a notoriously poor prognosis. Fusions involving oncogenes have been reported in gliomas and may serve as novel therapeutic targets to date. Understanding the gene fusions and how they regulate oncogenesis and malignant progression will contribute to explore new approaches for personalized treatment. By now, studies on gene fusions in gliomas remain limited. However, some current clinical trials targeting fusion genes have presented exciting preliminary findings. The aim of this review is to summarize all the reported fusion genes in high-grade gliomas so far, discuss the characterization of some of the most popular gene fusions occurring in malignant gliomas, as well as their function in tumorigenesis, and the underlying clinical implication as therapeutic targets. |
topic |
fusion gene high-grade glioma glioblastoma targeted therapy personalized cancer medicine |
url |
https://www.frontiersin.org/articles/10.3389/fneur.2021.715206/full |
work_keys_str_mv |
AT ganyou fusiongenesalteredinadultmalignantgliomas AT ganyou fusiongenesalteredinadultmalignantgliomas AT xingfan fusiongenesalteredinadultmalignantgliomas AT huiminhu fusiongenesalteredinadultmalignantgliomas AT taojiang fusiongenesalteredinadultmalignantgliomas AT taojiang fusiongenesalteredinadultmalignantgliomas AT clarkcchen fusiongenesalteredinadultmalignantgliomas |
_version_ |
1716844389025710080 |